Antibody specific for human IL-4 for the treament of cancer

Details for Australian Patent Application No. 2007228943 (hide)

Owner Apogenix GmbH

Inventors Gamer, Jurgen; Stassi, Giorgio; Todaro, Matilde; Hoger, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2007228943

PCT Pub. Number WO2007/107349

Priority 06 005 894.8 22.03.06 EP

Filing date 21 March 2007

Wipo publication date 27 September 2007

Acceptance publication date 22 March 2012

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/107349 Priority application(s): WO2007/107349

22 March 2012 Application Accepted

  Published as AU-B-2007228943

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007228951-Microparticles comprising a crosslinked polymer

2007228940-Substituted indazole derivatives, their manufacture and use as pharmaceutical agents